These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31967406)

  • 1. H
    Suzuki S; Kaikita K; Yamamoto E; Sueta D; Yamamoto M; Ishii M; Ito M; Fujisue K; Kanazawa H; Araki S; Arima Y; Takashio S; Usuku H; Nakamura T; Sakamoto K; Izumiya Y; Soejima H; Kawano H; Jinnouchi H; Matsui K; Tsujita K
    ESC Heart Fail; 2020 Feb; 7(1):65-74. PubMed ID: 31967406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of H
    Sun Y; Wang N; Li X; Zhang Y; Yang J; Tse G; Liu Y
    ESC Heart Fail; 2021 Apr; 8(2):1244-1252. PubMed ID: 33403825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the H
    Ludwig S; Pellegrini C; Gossling A; Rheude T; Voigtländer L; Bhadra OD; Linder M; Kalbacher D; Koell B; Waldschmidt L; Schirmer J; Seiffert M; Reichenspurner H; Blankenberg S; Westermann D; Conradi L; Joner M; Schofer N
    ESC Heart Fail; 2021 Feb; 8(1):461-470. PubMed ID: 33215870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H
    Vasilev V; Popovic D; Ristic GG; Arena R; Radunovic G; Ristic A
    Clin Cardiol; 2021 Jul; 44(7):946-954. PubMed ID: 34075600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H2FPEF Score as a Prognostic Value in HFpEF Patients.
    Sueta D; Yamamoto E; Nishihara T; Tokitsu T; Fujisue K; Oike F; Takae M; Usuku H; Takashio S; Arima Y; Suzuki S; Nakamura T; Ito M; Kanazawa H; Sakamoto K; Kaikita K; Tsujita K
    Am J Hypertens; 2019 Oct; 32(11):1082-1090. PubMed ID: 31271191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ventilatory abnormalities and prognostic values of H
    Huang WM; Cheng HM; Yu WC; Guo CY; Chiang CE; Chen CH; Sung SH
    ESC Heart Fail; 2020 Aug; 7(4):1872-1879. PubMed ID: 32488965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems.
    Parcha V; Malla G; Kalra R; Patel N; Sanders-van Wijk S; Pandey A; Shah SJ; Arora G; Arora P
    ESC Heart Fail; 2021 Jun; 8(3):2089-2102. PubMed ID: 33709628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the HFA-PEFF and H
    Tomasoni D; Aimo A; Merlo M; Nardi M; Adamo M; Bellicini MG; Cani D; Franzini M; Khalil A; Pancaldi E; Panichella G; Porcari A; Rossi M; Vergaro G; Lombardi CM; Sinagra G; Rapezzi C; Emdin M; Metra M
    Eur J Heart Fail; 2022 Dec; 24(12):2374-2386. PubMed ID: 35855616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the ESC 2016, H
    Nikorowitsch J; Bei der Kellen R; Kirchhof P; Magnussen C; Jagodzinski A; Schnabel RB; Blankenberg S; Wenzel JP
    ESC Heart Fail; 2021 Oct; 8(5):3603-3612. PubMed ID: 34459154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of SVI/S' and diagnostic scores for heart failure with preserved ejection fraction.
    Mu G; Wang W; Liu C; Xie J; Zhang H; Zhang X; Che J; Tse G; Liu T; Li G; Fu H; Chen K
    Clin Exp Pharmacol Physiol; 2023 Aug; 50(8):677-687. PubMed ID: 37203426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic scores predict morbidity and mortality in patients hospitalized for heart failure with preserved ejection fraction.
    Verbrugge FH; Reddy YNV; Sorimachi H; Omote K; Carter RE; Borlaug BA
    Eur J Heart Fail; 2021 Jun; 23(6):954-963. PubMed ID: 33634544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac amyloidosis: a significant blind spot of the H2FPEF score.
    Duca F; Rettl R; Binder C; Dusik F; Schrutka L; Dalos D; Öztürk B; Capelle CD; Qin H; Dachs TM; Camuz Ligios L; Agis H; Kain R; Hengstenberg C; Badr-Eslam R; Kastner J; Bonderman D
    Panminerva Med; 2023 Dec; 65(4):491-498. PubMed ID: 36789997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.
    Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events.
    Liang HY; Cauduro SA; Pellikka PA; Bailey KR; Grossardt BR; Yang EH; Rihal C; Seward JB; Miller FA; Abraham TP
    Am J Cardiol; 2006 Mar; 97(6):866-71. PubMed ID: 16516591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
    Alba AC; Buchan TA; Saha S; Fan S; Demers C; Poon S; Mak S; Al-Hesayen A; Toma M; Zieroth S; Anderson K; Porepa L; Chih S; Giannetti N; Rac V; Levy WC; Ross HJ; Guyatt GH
    Circ Heart Fail; 2023 Jul; 16(7):e010312. PubMed ID: 37337896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.